Shorter blood thinner use after heart stents in older adults
Part of Heart & circulation clinical trials.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years or older.
- You had a heart procedure (PCI) where at least one drug-eluting stent was placed successfully.
- You are not currently taking blood-thinning medication (like warfarin) for other conditions.
- Your kidneys must be working well enough (no severe kidney disease or dialysis).
- You must not have had recent bleeding problems, a stroke within the past month, or a brain injury within the past six months.
- Your heart blockages should not be extremely complex or require very long stents.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing two durations of antiplatelet therapy (blood thinners) after getting a heart stent, using ultrasound guidance to tailor the treatment. The goal is to find a shorter, safer medication plan that still prevents blood clots and heart attacks.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This Phase 4 study tests whether using a reduced blood-thinner (antithrombotic) strategy after a heart attack can lower bleeding without losing heart protection. It is mainly for people considered high risk for bleeding after getting a stent.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
Hear when a new Antiplatelet Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.